Summary

535.00 -6.34(-1.17%)01/16/2026
Intuitive Surgical, Inc. (ISRG)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 Years
-1.172.525.0123.575.217.89139.08


Last 730 data points are shown. To view all data, Upgrade to PRO plan!


Fundamental Ratings
CategoryRating
Main RatingB-
Recommended RatingNeutral
DCFNeutral
ROEBuy
ROAStrong Buy
Debt/EquityStrong Sell
P/EStrong Sell
P/BStrong Sell


Earnings
  • ISRG reported last earnings on 2025-10-21 after the market.
  • An EPS of $2.4 was observed compared to an estimated EPS of $1.99, resulting in a surprise value of $0.41.
  • A revenue of $2,505 million was observed compared to an estimated revenue of $2,406 million, resulting in a surprise value of $99 Million.


  • Trading Data
    Close535.00
    Open542.00
    High543.00
    Low532.63
    Volume3,015,488
    Change-6.34
    Change %-1.17
    Avg Volume (20 Days)2,093,459
    Volume/Avg Volume (20 Days) Ratio1.44
    52 Week Range430.30 - 616.00
    Price vs 52 Week High-13.15%
    Price vs 52 Week Low24.33%
    Range0.00
    Gap Up/Down-6.33
    Profitibility
    Market Capitalization (Mln)202,064
    Revenue per share26.9546
    Net Income per share7.7030
    Dividend Yield0.0000
    Dividend Share0.00%
    Valuations
    Enterprise Value0.00%
    PE Ratio69.4620
    PB Ratio0.0000
    PTB Ratio0.0000
    Liquidity
    Debt/Equity Ratio0.0000
    Net Debt/EBIDTA Ratio0.0000
    Current Ratio0.0000
    Enterprise Value and Cash Flow
    EV/Sales Ratio0.0000
    EV/EBIDTA Ratio0.0000
    EV/Free Cash Flow Ratio0.0000


    01/19 12:41 EST - forbes.com
    Is PODD A Better Bet Than ISRG Stock?
    PODD is Intuitive Surgical's counterpart in the Health Care Equipment sector that has:
    01/19 10:47 EST - fool.com
    The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever
    Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie's immunosuppressant portfolio helps it to produce steady revenue and profits.
    01/19 09:50 EST - zacks.com
    AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
    Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.
    01/19 04:44 EST - fool.com
    My Forever Portfolio: 5 Stocks I Don't Plan on Ever Selling
    This "forever" portfolio includes two "Magnificent Seven" stocks that should remain magnificent. It features a conglomerate that's preserving its long-time leader's legacy.
    01/18 03:17 EST - defenseworld.net
    Amalgamated Bank Has $36.96 Million Stock Position in Intuitive Surgical, Inc. $ISRG
    Amalgamated Bank raised its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.3% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 82,636 shares of the medical equipment provider's stock after buying an additional 1,094 shares...
    01/16 13:50 EST - zacks.com
    Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
    ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.
    01/16 12:29 EST - seekingalpha.com
    Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
    Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples...
    01/16 10:31 EST - zacks.com
    Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
    Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
    01/16 10:15 EST - zacks.com
    Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
    Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
    01/16 09:30 EST - investors.com
    Surging Intel Stock, 2 Other Nasdaq 100 Giants Headline Earnings Calendar
    Intel stock is holding near highs ahead of its Q4 earnings report, along with Leaderboard stock GE Aerospace.
    01/14 15:15 EST - seekingalpha.com
    Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
    Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
    01/14 12:14 EST - gurufocus.com
    Intuitive Surgical Updates Q4 Revenue Guidance Amid Growth Concerns
    Intuitive Surgical (ISRG) has increased its Q4 revenue guidance to approximately $2.866 billion, up from the previous estimate of $2.72 billion. Despite this, t
    01/14 12:12 EST - gurufocus.com
    Why Intuitive Surgical Stock Is Falling Today
    Intuitive Surgical (ISRG) slipped about 5% in Wednesday trading after providing 2026 growth projections for its Da Vinci surgical systems that came slightly bel
    01/14 12:07 EST - feeds.benzinga.com
    What's Going On With Intuitive Surgical Stock Wednesday?
    Intuitive Surgical stock fell after reporting Q4 and full-year 2025 results. Procedures, placements, and revenue all saw gains.
    01/14 11:18 EST - fool.com
    Why Intuitive Surgical Stock Dropped Today
    Intuitive pre-announced sales results for Q4 today -- and growth is slowing down. Full-year and Q4 earnings results won't come out for another week.
    01/14 11:15 EST - fool.com
    Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
    These players each are leaders in their specialty areas and have generated billions of dollars in revenue. This list includes a biotech stock, a pharma player, and a medical device company.
    01/14 09:05 EST - globenewswire.com
    Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
    SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results...
    01/14 08:20 EST - zacks.com
    da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
    ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
    01/12 06:38 EST - defenseworld.net
    Trilogy Capital Inc. Raises Position in Intuitive Surgical, Inc. $ISRG
    Trilogy Capital Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 23.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,406 shares of the medical equipment provider's stock after buying an additional...
    01/12 01:10 EST - defenseworld.net
    Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Rating of “Moderate Buy” by Analysts
    Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-seven research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold...

    Market News ×
    Loading news…